STOCK TITAN

Tenet Healthcare (NYSE: THC) director Roy Blunt granted 1,188 RSUs as equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Blunt Roy reported acquisition or exercise transactions in this Form 4 filing.

Tenet Healthcare director Roy Blunt received a grant of 1,188 restricted stock units as compensation. These 2026 May Restricted Stock Units were awarded at a price of $0.00 per unit and are economically equivalent to 1,188 shares of Tenet common stock.

The units vest on the first anniversary of the grant date, so they are scheduled to vest on May 27, 2027, if service-based conditions are met. After this grant, Blunt holds 1,188 restricted stock units directly. He may elect to receive up to 37% of these vested units in cash instead of shares, which gives some flexibility in how the award is settled.

Positive

  • None.

Negative

  • None.

Insights

Routine director RSU grant; no open-market buying or selling.

This filing shows director Roy Blunt received 1,188 restricted stock units under Tenet Healthcare’s stock incentive plan. Code A indicates a grant/award, not a market transaction, and the transaction price is listed as $0.00 per unit.

The RSUs vest on May 27, 2027, functioning as time-based compensation to align director interests with shareholders. Each RSU equals one common share economically, but up to 37% may be settled in cash at the director’s election, which slightly reduces direct share issuance.

There are no sales, option exercises, or tax-withholding dispositions in this report. From an investor perspective, this is a standard governance and compensation event, with a modest equity-based award and limited immediate impact on Tenet’s share count.

Insider Blunt Roy
Role null
Type Security Shares Price Value
Grant/Award 2026 May Restricted Stock Units 1,188 $0.00 --
Holdings After Transaction: 2026 May Restricted Stock Units — 1,188 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 1,188 units 2026 May Restricted Stock Units grant
Transaction price $0.00 per unit Grant of restricted stock units
Underlying common shares 1,188 shares Economic equivalent of RSUs
Cash election limit 37% of RSUs Portion of award may be settled in cash
Vesting date May 27, 2027 First anniversary of grant date
Restricted Stock Units financial
"Represents restricted stock units granted under the Company's Stock Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Incentive Plan financial
"Represents restricted stock units granted under the Company's Stock Incentive Plan."
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
economic equivalent financial
"Each restricted stock unit is the economic equivalent of one share of the Company's common stock."
vest financial
"These restricted stock units vest on the first anniversary of the date of grant."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
cash in lieu of shares financial
"The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blunt Roy

(Last)(First)(Middle)
14201 DALLAS PARKWAY

(Street)
DALLAS TEXAS 75254

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
2026 May Restricted Stock Units(1)05/27/2026A1,18805/27/202705/27/2027Common Stock1,188$01,188D
Explanation of Responses:
1. Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.
Chad J. Wiener, as Attorney-in-fact for Roy Blunt05/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Tenet Healthcare (THC) director Roy Blunt report on this Form 4?

Roy Blunt reported receiving 1,188 restricted stock units as an equity award. These units were granted at a stated price of $0.00 per unit under Tenet Healthcare’s stock incentive plan and represent equity-based director compensation, not an open-market stock purchase or sale.

How many Tenet Healthcare RSUs did Roy Blunt receive in this grant?

Roy Blunt received 1,188 restricted stock units tied to Tenet Healthcare common stock. Each restricted stock unit is economically equivalent to one share of common stock, so the award represents potential delivery of 1,188 shares, subject to vesting and any cash elections allowed under the plan.

When do Roy Blunt’s 1,188 Tenet Healthcare restricted stock units vest?

The 1,188 restricted stock units vest on the first anniversary of the grant date. Based on the reported grant date of May 27, 2026, the units are scheduled to vest on May 27, 2027, assuming any required service conditions continue to be satisfied through that date.

Can Roy Blunt receive cash instead of Tenet Healthcare shares for these RSUs?

Yes. The footnote states Blunt may elect to receive up to 37% of these restricted stock units in cash instead of shares. This means a portion of the vested award can be settled in cash, while the remainder would typically be delivered in Tenet Healthcare common stock.

Does this Tenet Healthcare Form 4 show any stock sales by Roy Blunt?

No. The filing only reports an acquisition of 1,188 restricted stock units coded as a grant or award. There are no reported open-market stock sales, option exercises, gifts, or tax-withholding dispositions in this Form 4, making it a routine equity compensation disclosure.

How many Tenet Healthcare RSUs does Roy Blunt hold after this transaction?

After this transaction, Roy Blunt holds 1,188 restricted stock units according to the filing. The total shares following the transaction field matches the number granted, indicating this award establishes his reported RSU position in Tenet Healthcare common stock at that time.